We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Analysis of Volatile Substances in Breath of Pneumonia Patients Confirms Fungal Infection Diagnosis

By LabMedica International staff writers
Posted on 03 Nov 2014
Print article
Image: Conidiophores of Aspergillus fumigatus (Photo courtesy of the CDC - [US] Centers for Disease Control and Prevention).
Image: Conidiophores of Aspergillus fumigatus (Photo courtesy of the CDC - [US] Centers for Disease Control and Prevention).
Analysis of volatile substances in the breath of patients with respiratory infections has been proposed as a novel, noninvasive, pathogen-specific approach to identifying the precise microbial cause of pneumonia.

Investigators at Brigham and Women's Hospital (Boston, MA, USA) were particularly interested in the fungus Aspergillus fumigatus, which causes an often fatal type of pneumonia in patients with compromised immune systems.

The investigators first identified unique volatile substances produce by A. fumigatus growing in Petri dishes and then used thermal desorption-gas chromatography/mass spectrometry to attempt to detect these substances in the breath of pneumonia patients.

Among the distinctive substances produced by cultures of A. fumigatus that could be used to distinguish it from other pathogenic aspergilli were the monoterpenes camphene, alpha- and beta-pinene, and limonene and the sesquiterpene compounds alpha- and beta-trans-bergamotene.

The investigators analyzed breath samples that had been collected from 2011 to 2013 from 64 patients with suspected invasive fungal pneumonia. Results revealed that of the 64 patients who had been diagnosed with suspected invasive fungal pneumonia based on host risk factors, clinical symptoms, and radiological findings, 34 were diagnosed with invasive aspergillosis, whereas 30 were ultimately diagnosed with other causes of pneumonia, including other invasive fungal infection. Detection of alpha-trans-bergamotene, beta-trans-bergamotene, a beta-vatirenene-like sesquiterpene, or trans-geranylacetone identified invasive aspergillosis patients with 94% sensitivity and 93% specificity.

"Identification of the underlying microbial etiology remains elusive in most patients with pneumonia, even with invasive diagnostic measures," said first author Dr. Sophia Koo, assistant professor of medicine at Brigham and Women's Hospital. "Our findings provide proof-of-concept that we can harness detection of species-specific metabolites to identify the precise microbial cause of pneumonia, which may guide appropriate treatment of these infections. We can likely also use this volatile metabolite profiling approach to identify other, more common causes of pneumonia."

The proof-of-concept study was published in the October 22, 2014, online edition of the journal Clinical Infectious Diseases.

Related Links:

Brigham and Women's Hospital




Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria (Photo courtesy of Roche)

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. Other transmission modes include blood transfusions, organ transplants,... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.